beta-lapachone has been researched along with Diffuse Large B-Cell Lymphoma in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lim, SM | 1 |
| Jeong, Y | 1 |
| Lee, S | 1 |
| Im, H | 1 |
| Tae, HS | 1 |
| Kim, BG | 1 |
| Park, HD | 1 |
| Park, J | 1 |
| Hong, S | 1 |
1 other study available for beta-lapachone and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Identification of β-Lapachone Analogs as Novel MALT1 Inhibitors To Treat an Aggressive Subtype of Diffuse Large B-Cell Lymphoma.
Topics: Antineoplastic Agents; Caspases; Cell Line, Tumor; Cell Proliferation; Humans; Lymphoma, Large B-Cel | 2015 |